Related references
Note: Only part of the references are listed.A phase 2 prospective trial of cabozantinib as first-line treatment for metastatic collecting ducts renal cell carcinoma: The BONSAI trial (Meeturo 2) clinical trial information-NCT03354884.
Giuseppe Procopio et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Alessandro Carugo et al.
CANCER CELL (2019)
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma
Chisato Ohe et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib
Alessia Mennitto et al.
CLINICAL GENITOURINARY CANCER (2018)
Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy A case report
Shotaro Yasuoka et al.
MEDICINE (2018)
Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database
Wilson Sui et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report
Kosuke Mizutani et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Anti-programmed Death Receptor 1 Blockade Induces Clinical Response in a Patient With Metastatic Collecting Duct Carcinoma
Kalen J. Rimar et al.
CLINICAL GENITOURINARY CANCER (2016)
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling
Sumanta K. Pal et al.
EUROPEAN UROLOGY (2016)
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation
Jianmin Wang et al.
ONCOTARGET (2016)
Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas
Gabriel G. Malouf et al.
SCIENTIFIC REPORTS (2016)
Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
Cynthia Wetmore et al.
NEURO-ONCOLOGY (2015)
Clinical Features and Treatment of Collecting Duct Carcinoma of the Kidney from the Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee
Kyung A. Kwon et al.
CANCER RESEARCH AND TREATMENT (2014)
Management of renal collecting duct carcinoma: a systematic review and the McMaster experience
S. Dason et al.
CURRENT ONCOLOGY (2013)
Carcinoma of the Collecting Ducts of Bellini and Renal Medullary Carcinoma Clinicopathologic Analysis of 52 Cases of Rare Aggressive Subtypes of Renal Cell Carcinoma With a Focus on Their Interrelationship
Ruta Gupta et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Response of Metastatic Renal Medullary Carcinoma to Carboplatinum and Paclitaxel Chemotherapy
Venu Gopala Reddy Gangireddy et al.
CLINICAL GENITOURINARY CANCER (2012)
HER2 Blockade in Metastatic Collecting Duct Carcinoma (CDC) of the Kidney: A Case Report
Miguel H. Bronchud et al.
ONKOLOGIE (2012)
Characteristics and Outcomes of Tumors Arising From the Distal Nephron
Michael R. Abern et al.
UROLOGY (2012)
Complete Response to Carboplatin, Gemcitabine, and Paclitaxel in a Patient With Advanced Metastatic Renal Medullary Carcinoma
Alexandra Walsh et al.
PEDIATRIC BLOOD & CANCER (2010)
Renal medullary carcinoma: Remission with gemcitabine-cisplatin and review of therapeutic perspectives
B. Diao et al.
PROGRES EN UROLOGIE (2010)
Carcinoma of the Collecting Ducts of Bellini of the Kidney: Adjuvant Chemotherapy Followed by Multikinase Inhibition with Sunitinib
Michael Staehler et al.
CLINICAL GENITOURINARY CANCER (2009)
Influence of Demographic Factors on Outcome of Collecting Duct Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis
Joseph M. Pepek et al.
CLINICAL GENITOURINARY CANCER (2009)
Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report
M. Mego et al.
ANNALS OF ONCOLOGY (2008)
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: Results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Genitales) study
Setphane Oudard et al.
JOURNAL OF UROLOGY (2007)
Share Paper
